menu
    • menu

    Company profile for Dren Bio

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dren’s team has profound expertise in antibody executed elimination of pathological cells. We selectively engage an effector cell for targeted depletion of diseased cells or agents. The company’s pipeline has two lead programs: DR-01 utilizes antibody-mediated killing of a cell type involved in leukemia, lymphomas and autoimmune diseases, Initially targeting neglected HemOnc indications with no approved therapies and expa...
    Dren’s team has profound expertise in antibody executed elimination of pathological cells. We selectively engage an effector cell for targeted depletion of diseased cells or agents. The company’s pipeline has two lead programs: DR-01 utilizes antibody-mediated killing of a cell type involved in leukemia, lymphomas and autoimmune diseases, Initially targeting neglected HemOnc indications with no approved therapies and expansion into defined subsets of autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dren BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Carlos, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.drenbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
    Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Dren Bio Wins 2025 Prix Galien USA For Top Biotech Startup
    Dren Bio Wins 2025 Prix Galien USA For Top Biotech Startup

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104340462/en/Dren-Bio-Receives-Prestigious-2025-Prix-Galien-USA-Award-for-Best-Biotech-Startup

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Sanofi Completes Acquisition of DR-0201
    Sanofi Completes Acquisition of DR-0201

    27 May 2025

    // PRESS RELEASE

    https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324

    PRESS RELEASE
    27 May 2025
    Share Share
    Sanofi to acquire Dren Bio's immunology unit
    Sanofi to acquire Dren Bio's immunology unit

    20 Mar 2025

    // PRESS RELEASE

    https://www.sanofi.com/assets/dotcom/pressreleases/2025/2025-03-20-06-00-00-3045945-en.pdf

    PRESS RELEASE
    20 Mar 2025
    Share Share
    Novartis taps Dren Bio in $3B pact focused on myeloid engagers
    Novartis taps Dren Bio in $3B pact focused on myeloid engagers

    24 Jul 2024

    // ENDPTS

    https://endpts.com/novartis-pays-150m-upfront-including-25m-in-equity-for-dren-bios-bispecifics/

    ENDPTS
    24 Jul 2024
    Share Share
    Dren Bio And Novartis Partner On Cancer Myeloid Engagers
    Dren Bio And Novartis Partner On Cancer Myeloid Engagers

    24 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240724830878/en

    BUSINESSWIRE
    24 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search